發佈日期：2014年2月6日
糖尿病新藥-SGLT2抑制劑助排糖 腎功能不佳者不適用
The management of Type 2 Diabetes (T2D) is complex and challenging.
Sodium glucose cotransporter 2 (SGLT2) inhibition offers a different mode of action from other oral glucose lowering treatments.
Find out more about SGLT2 inhibition and its potential impact on T2D management.
請先 登入 以發表留言。